From: Evaluation of public subsidy for medical travel: does it protect against household impoverishment?
Disease Group (ICD 10) | Medical cost during last episode of treatment abroad | Richest 5% | Poorest 5% | Percentile ratio | Poverty head count ratio | Proportion of financial protection | |||
---|---|---|---|---|---|---|---|---|---|
N | Median (IQR) | 95th percentile | 5th percentile | Gross | Net | Difference | % | ||
Diseases of the circulatory system | 82 | 926.54 (266, 2625) | 12,128.9 | 124.7 | 97.3 | 3% | 18% | 16% | 57.3 |
Diseases of nervous system | 69 | 795.13 (305, 1474) | 7237.2 | 127.9 | 56.6 | 0% | 2% | 2% | 33.3 |
Diseases of musculoskeletal system | 65 | 603.39 (218, 1072) | 2111.9 | 73.2 | 28.8 | 6% | 16% | 10% | 15.4 |
Diseases of genitourinary system | 62 | 808.54 (305, 1331) | 4009.2 | 67.1 | 59.7 | 10% | 18% | 8% | 54.8 |
Diseases of the eye & adnexa | 51 | 492.09 (156, 1149) | 2136.0 | 52.3 | 40.8 | 17% | 28% | 11% | 54.9 |
Neoplasms | 51 | 1193.37 (412, 4312) | 9589.2 | 83.8 | 114.4 | 2% | 7% | 5% | 86.3 |